http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#Head
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#assertion
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#provenance
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#pubinfo
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#assertion
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
https://identifiers.org/MONDO:0005384
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/CHEBI:42797
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association
http://www.w3.org/2000/01/rdf-schema#label
Gabapentin capsules, USP are indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. Gabapentin capsules, USP are also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 to 12 years.
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association
https://w3id.org/biolink/vocab/has_population_context
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#cohort
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association
https://w3id.org/biolink/vocab/provided_by
NeuroDKG
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association
https://w3id.org/biolink/vocab/publications
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0936a88f-b569-49c4-951b-14e8f6273b53
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#cohort
http://www.w3.org/2000/01/rdf-schema#label
patients over 12 years of age with epilepsy; pediatric patients age 3 to 12 years
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#cohort
https://schema.org/requiredMinAge
3
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#cohort
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Cohort
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#cohort
https://w3id.org/biolink/vocab/has_phenotype
https://identifiers.org/MONDO:0005027
https://identifiers.org/CHEBI:42797
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
https://identifiers.org/MONDO:0005384
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#provenance
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#pubinfo
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#sig
http://purl.org/nanopub/x/hasSignature
GVpwbVsPxdD1f0XxN6kIIbt3FXkUD3+ag41SVjR6oHAYRWweMYyWsf8tqTaWLj6rJAonzXr0SSgy7RU5lT7angfwR07qLMOmCz/2biSDvAMoyaW8xaiEHw1OpUNzZkphxiRZbE/tM2Y0YpJWkjtxJcWASd8NS2QbXRFHdCIagbA=
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk
http://purl.org/dc/terms/created
2021-03-28T18:53:09.384+02:00
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RA59AEpaWRaR9sjdA0-n4zaQWdiZ6--iGafMrjrDAOheI